Pharma channel feed

Roche wins ear­li­er-than-ex­pect­ed ap­proval for block­buster Tecen­triq in rare soft tis­sue can­cer

3 years ago
FDA+

Mar­ket­ingRx roundup: Pfiz­er teams with NFL play­er for sick­le cell aware­ness; Astel­las crowd­sources pa­tient so­lu­tions

3 years ago
Marketing

#ASH22: No­var­tis PNH drug tops As­traZeneca with what's de­scribed as 'prac­tice-chang­ing' po­ten­tial

3 years ago
R&D

Ab­bott heads up new ad­vo­ca­cy ef­fort for con­cus­sion aware­ness with spokesper­son, ac­tress Rebel Wil­son

3 years ago
Marketing

Up­dat­ed: FDA ap­proves Mi­rati's KRAS drug in non-small cell lung can­cer

3 years ago
R&D
FDA+

#ASH22: Re­gen­eron claims it has set a 'new bench­mark' in fol­lic­u­lar lym­phoma

3 years ago
R&D

Seagen rolls out da­ta for Ad­cetris com­bi­na­tion to treat Hodgkin lym­phoma

3 years ago

Sanofi teams up sci­ence and sports for Paris 2024 Olympics spon­sor­ship, ex­tend­ing its #WeN­ev­er­Set­tle ethos

3 years ago
Marketing

Clin­i­cal tri­al brand­ing? Biotechs and phar­mas mi­grate name and iden­ti­ty strate­gies even ear­li­er

3 years ago
Marketing

Bill An­der­son to step down as Roche phar­ma chief by mon­th's end

3 years ago
People

Up­dat­ed: Hori­zon's $28B sale to Am­gen was kicked off by Sanofi's in­ter­est

3 years ago
Deals

Up­dat­ed: Am­gen in ad­vanced talks for Hori­zon, WSJ re­ports; Sanofi pulls out

3 years ago
Deals

#ASH22: Re­gen­eron re­veals its first PhII da­ta in con­test­ed CD20xC3 bis­pe­cif­ic race

3 years ago
R&D

#ASH22: J&J touts first PhII re­sults of next-gen mul­ti­ple myelo­ma an­ti­body

3 years ago
R&D
Cell/Gene Tx

Val­isure in the hot seat: New Form 483 over a 2021 in­spec­tion as CEO fires back

3 years ago
FDA+
Manufacturing

Mov­ing to the em­ploy­er side of health­care, Mark Cuban's Cost Plus Drugs part­ners with a PBM

3 years ago

Bags of shred­ded docs: In­di­an drug­mak­er Lupin hand­ed a Form 483 by FDA in­spec­tors

3 years ago
FDA+
Manufacturing

Ab­b­Vie slapped with age dis­crim­i­na­tion law­suit, fol­low­ing oth­er phar­mas

3 years ago
Law

Sen­ate Fi­nance chair goes af­ter Am­gen again on US tax­es, ask­ing for pay­ment specifics

3 years ago
Law

Take­da nabs dengue vac­cine ap­proval in Eu­rope, as trav­el, cli­mate change con­tribute to rise in cas­es

3 years ago
Marketing

FDA au­tho­rizes bi­va­lent Covid boost­ers for chil­dren 6 months and up

3 years ago
FDA+
Coronavirus

Pub­li­cis for­goes light­heart­ed hol­i­day mes­sage for more se­ri­ous HPV warn­ing with celebri­ty guest

3 years ago
Marketing

Nashville-based CD­MO nets a $65M Se­ries B to ex­pand fa­cil­i­ty and ca­pa­bil­i­ties

3 years ago
Financing
Manufacturing

QC vi­o­la­tions raised by FDA at an­oth­er Au­robindo site

3 years ago
FDA+
Manufacturing
First page Previous page 156157158159160161162 Next page Last page
A service from the Financial Times